139 related articles for article (PubMed ID: 8029886)
1. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.
Jeyarajah DR; Schmeisser FS; Kadakia RA; Thistlethwaite JR
Transplant Proc; 1994 Jun; 26(3):1201-2. PubMed ID: 8029886
[No Abstract] [Full Text] [Related]
2. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
[No Abstract] [Full Text] [Related]
3. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
[No Abstract] [Full Text] [Related]
4. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
[No Abstract] [Full Text] [Related]
5. Effect of rapamycin on islet and skin xenograft survival.
Bobbio SA; Porter JG; Monaco AP
Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
[No Abstract] [Full Text] [Related]
6. Long-term functional xenograft tolerance after intrathymic islet transplantation (Lewis rat-->B6 mouse).
Zeng Y; Bluestone JA; Ildstad ST; Torres MA; Montag AG; Thistlethwaite RJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):438-9. PubMed ID: 8438368
[No Abstract] [Full Text] [Related]
7. Induction of immune unresponsiveness by intrathymic injection of allogeneic cells in a murine model.
Sherburne CG; Onyekaba CO; Condie RM
Transplant Proc; 1993 Feb; 25(1 Pt 1):307-11. PubMed ID: 8438313
[No Abstract] [Full Text] [Related]
8. Induction of extended survival of rat skin xenografts in mice by pretreatment with intrathymic xenoantigen and antilymphocyte serum.
Goss JA; Nakafusa Y; Uchiyama K; Flye MW
Transplantation; 1992 Dec; 54(6):1101-3. PubMed ID: 1465777
[No Abstract] [Full Text] [Related]
9. Skin allograft survival following intrathymic injection of donor bone marrow.
Cober SR; Randolph MA; Lee WP
J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
[TBL] [Abstract][Full Text] [Related]
10. Lack of cross-species sensitization between skin allo- and xenotransplants in mice.
Vizler C; Jánossy T; Tabi Z; Végh P
Transplant Proc; 1994 Jun; 26(3):1324-5. PubMed ID: 8029925
[No Abstract] [Full Text] [Related]
11. Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
De Fazio SR; Markees TG; Hartner WC; Gozzo JJ
Transplant Proc; 1995 Feb; 27(1):171-3. PubMed ID: 7878960
[No Abstract] [Full Text] [Related]
12. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
[No Abstract] [Full Text] [Related]
13. Inhibitory effect of the complement receptor-specific monoclonal antibody on the induced antibody response and the role of CD4+ and CD8+ T-cells in the rat to mouse xenotransplantation.
Matsumiya G; Shirakura R; Miyagawa S; Nakata S; Nakano S; Kinoshita T; Matsuda H
Transplant Proc; 1993 Feb; 25(1 Pt 1):402-4. PubMed ID: 8438354
[No Abstract] [Full Text] [Related]
14. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
[TBL] [Abstract][Full Text] [Related]
15. Humoral tolerance in mixed xenogeneic chimeras prepared by a nonmyeloablative conditioning regimen.
Aksentijevich I; Sharabi Y; Sundt TM; Sachs DH; Sykes M
Transplant Proc; 1991 Feb; 23(1 Pt 1):880-2. PubMed ID: 1990712
[No Abstract] [Full Text] [Related]
16. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
Gozzo JJ; Kowolenko M
Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
[No Abstract] [Full Text] [Related]
17. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
[No Abstract] [Full Text] [Related]
18. Effect of different temporary immunosuppressive therapies and low-temperature culture on pancreatic islet xenograft survival (pig-to-mouse).
Marchetti P; Scharp DW; Finke E; Swanson CJ; Gerasimidi-Vazeou A; Olack BJ; Navalesi R; Lacy PE
Transplant Proc; 1994 Apr; 26(2):760-1. PubMed ID: 8171651
[No Abstract] [Full Text] [Related]
19. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
[No Abstract] [Full Text] [Related]
20. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
Ito H; Takeuchi Y; Shaffer J; Sykes M
Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
